Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion type Assertion NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_head.
- NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion wasGeneratedBy ECO_0000203 NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_provenance.
- NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion wasDerivedFrom befree-20150227 NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_provenance.
- NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion SIO_000772 23086750 NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_provenance.
- NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion evidence source_evidence_literature NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_provenance.
- NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_assertion description "[We have assessed the impact of these mutations in a cohort of 494 patients treated within the randomized phase 3 United Kingdom Leukaemia Research Fund Chronic Lymphocytic Leukemia 4 (UK LRF CCL4) trial that compared chlorambucil and fludarabine with and without cyclophosphamide in previously untreated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904670.RAE1Wy_JZawu-ACOWu-157SryBZoa-2HkP4PhjuYop0vA130_provenance.